Wear it pink this October At work. At school. At home. Wherever you do it, wear pink and raise money to fund life-changing research and support
Home About us Media Breast Cancer Now media statements 166 results We respond to news that the pandemic ‘threatens research as early career scientists look to leave’ 10 Nov 2020 1 min read We support recommendations for faster and wider access to innovative cancer treatments 09 Nov 2020 1 min read We welcome SMC approval of adjuvant Kadcyla and atezolizumab with nab-paclitaxel for use on the NHS 09 Nov 2020 3 min read We respond to ‘plasmaMATCH’ trial that uses blood test to match women with breast cancer to a range of precision treatments 11 Sept 2020 1 min read We respond to Ali Bastian's breast cancer diagnosis 09 Sept 2024 1 min read Breast Cancer Now responds to latest vacancy rates among screening mammographers 15 Aug 2024 1 min read Breast Cancer Now responds to racist violence across the UK 07 Aug 2024 1 min read We respond to new data presented at ASCO 2024 congress, which found that women taking Enhertu survived without their breast cancer growing for an average of 13 months 03 Jun 2024 2 min read Talazoparib (Talzenna) approved for use on the NHS in Scotland 11 Mar 2024 2 min read Breast Cancer Now flags concerns over findings of final PAC Report 01 Mar 2023 1 min read Previous 1 ... 13 14 Next
We respond to news that the pandemic ‘threatens research as early career scientists look to leave’ 10 Nov 2020 1 min read
We support recommendations for faster and wider access to innovative cancer treatments 09 Nov 2020 1 min read
We welcome SMC approval of adjuvant Kadcyla and atezolizumab with nab-paclitaxel for use on the NHS 09 Nov 2020 3 min read
We respond to ‘plasmaMATCH’ trial that uses blood test to match women with breast cancer to a range of precision treatments 11 Sept 2020 1 min read
Breast Cancer Now responds to latest vacancy rates among screening mammographers 15 Aug 2024 1 min read
We respond to new data presented at ASCO 2024 congress, which found that women taking Enhertu survived without their breast cancer growing for an average of 13 months 03 Jun 2024 2 min read
